DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT Trademark

Trademark Overview


On Wednesday, May 29, 2019, a trademark application was filed for DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT with the United States Patent and Trademark Office. The USPTO has given the DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT trademark a serial number of 88451500. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 9, 2020. This trademark is owned by Bayer HealthCare Pharmaceuticals Inc.. The DUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT trademark is filed in the Insurance & Financial Services category with the following description:

Financial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy; Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payer reimbursement for prescription drugs
dude access services darolutamide user drug enrollment

General Information


Serial Number88451500
Word MarkDUDE ACCESS SERVICES DAROLUTAMIDE USER DRUG ENROLLMENT
Filing DateWednesday, May 29, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 9, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word DUDE with a curved line and a dot over the second D. Above DUDE is the phrase ACCESS SERVICES and below that is Darolutamide User Drug Enrollment.
Goods and ServicesFinancial administration of health reimbursement arrangements; Financial management of reimbursement payments for others; Financial administration of medication reimbursement programs and services; Financial administration of patient reimbursement programs to provide medical insurance copay assistance to eligible patients to reduce the cost; Providing patients who have been prescribed a specific course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy; Prescription drug claims administration services, namely, facilitating authorization of health care insurance coverage, insurance claim submission and payer reimbursement for prescription drugs

Classification Information


International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, June 13, 2019
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBayer HealthCare Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWhippany, NJ 07981

Trademark Events


Event DateEvent Description
Monday, March 9, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, March 9, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, August 22, 2019NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, August 22, 2019EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Thursday, August 22, 2019COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Thursday, August 22, 2019EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, August 19, 2019ASSIGNED TO EXAMINER
Friday, June 14, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 1, 2019NEW APPLICATION ENTERED IN TRAM